Synergistic selenopeptide formulations for the protection of dermal papilla cells
US-9498423-B2 · Nov 22, 2016 · US
Adaptogenic compositions and applications thereof
US10716823B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10716823-B2 |
| Application number | US-201615051777-A |
| Country | US |
| Kind code | B2 |
| Filing date | Feb 24, 2016 |
| Priority date | Feb 24, 2016 |
| Publication date | Jul 21, 2020 |
| Grant date | Jul 21, 2020 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
Disclosed is the adaptogenic activity of boswellic acids-polysaccharide compositions derived from Boswellia serrata in combination with either (i) the concentrate of the liquid endosperm of Cocos nucifera or (ii) the extract of Emblica officinalis fruit standardized to contain 10% w/w and above of 1-O-galloyl-β-D-glucose (β-glucogallin).
First claim
Opening claim text (preview).
We claim: 1. A method of increasing physiological endurance in mammals subjected to strenuous physical activity, comprising a step of orally administering an effective amount of a composition consisting of: (a) 1 part Boswellic acids-polysaccharide (BP) extract derived from Boswellia serrata , wherein the extract contains is not less than 70% polysaccharides, and (b) 2 parts Emblica officinalis (EO) fruit extract standardized to contain at least 10% w/w and of 1-O-galloyl-β-D-glucose (β-glucogallin) and not more than 5% w/w of gallic acid, wherein the composition is administered once a day for a sufficient duration to bring about an increase in physiological endurance, and wherein the effective amount is 50 mg/kg body weight of the mammal. 2. A method of increasing physiological endurance in mammals subjected to strenuous physical activity, comprising a step of orally administering an effective amount of a composition consisting of: (a) 2 parts Boswellic acids-polysaccharide (BP) extract derived from Boswellia serrata , wherein the extract contains is not less than 70% polysaccharides, and (b) 1 part concentrate of the liquid endosperm of Cocos nucifera (CN), once a day, to bring about an increase in physiological endurance, wherein the composition is administered once a day for a sufficient duration to bring about an increase in physiological endurance, and wherein the effective amount is 100 mg/kg body weight of the mammal.
Assignees
Inventors
Classifications
Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean) · CPC title
Boswellia, e.g. frankincense · CPC title
Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters · CPC title
attached to a carbocyclic compound, e.g. phloridzin · CPC title
- A61K36/889Primary
Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US10716823B2 cover?
- Disclosed is the adaptogenic activity of boswellic acids-polysaccharide compositions derived from Boswellia serrata in combination with either (i) the concentrate of the liquid endosperm of Cocos nucifera or (ii) the extract of Emblica officinalis fruit standardized to contain 10% w/w and above of 1-O-galloyl-β-D-glucose (β-glucogallin).
- Who is the assignee on this patent?
- Majeed Muhammed, Nagabhushanam Kalyanam, Sami Labs Ltd
- What technology area does this patent fall under?
- Primary CPC classification A61K36/889. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Jul 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).